Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 6
Therapeutics and Clinical Risk Management
ISSN: 1178-203X
- View all (2328)
- Volume 20, 2024 (20)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 3, 2007
Shared decision-making based on different features of risk in the context of diabetes mellitus and rheumatoid arthritis
Monica Ortendahl
Therapeutics and Clinical Risk Management 2007, 3:1175-1180
Published Date: 15 January 2008
Update on the treatment of disseminated fusariosis: Focus on voriconazole
Marta Stanzani, Fabio Tumietto, Nicola Vianelli, Michele Baccarani
Therapeutics and Clinical Risk Management 2007, 3:1165-1173
Published Date: 15 January 2008
Treatment of non-alcoholic fatty liver disease
Keith G Tolman, Anthony S Dalpiaz
Therapeutics and Clinical Risk Management 2007, 3:1153-1163
Published Date: 15 January 2008
History and evolution of antibiotic resistance in coagulase-negative staphylococci: Susceptibility profiles of new anti-staphylococcal agents
Joseph F John, Alexander M Harvin
Therapeutics and Clinical Risk Management 2007, 3:1143-1152
Published Date: 15 January 2008
Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
Todd M Cooper
Therapeutics and Clinical Risk Management 2007, 3:1135-1141
Published Date: 15 January 2008
Update on the treatment of ankylosing spondylitis
Walter P Maksymowych
Therapeutics and Clinical Risk Management 2007, 3:1125-1133
Published Date: 15 January 2008
Rivastigmine in Alzheimer’s disease: Cognitive function and quality of life
Roberta Annicchiarico, Alessia Federici, Carla Pettenati, Carlo Caltagirone
Therapeutics and Clinical Risk Management 2007, 3:1113-1123
Published Date: 15 January 2008
Obstructive sleep apnea and cardiovascular risk
Punginathn Dorasamy
Therapeutics and Clinical Risk Management 2007, 3:1105-1111
Published Date: 15 January 2008
Review of tenofovir-emtricitabine
Saba Woldemichael Masho, Cun-Lin Wang, Daniel E Nixon
Therapeutics and Clinical Risk Management 2007, 3:1097-1104
Published Date: 15 January 2008
Topotecan: An evolving option in the treatment of relapsed small cell lung cancer
Jennifer Garst
Therapeutics and Clinical Risk Management 2007, 3:1087-1095
Published Date: 15 January 2008
The role of entecavir in the treatment of chronic hepatitis B
Evangelini Dimou, Vasilios Papadimitropoulos, Stephanos J Hadziyannis
Therapeutics and Clinical Risk Management 2007, 3:1077-1086
Published Date: 15 January 2008
Vaccination against hepatitis A in children: A review of the evidence
Paolo Bonanni, Sara Boccalini, Angela Bechini
Therapeutics and Clinical Risk Management 2007, 3:1071-1076
Published Date: 15 January 2008
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections
Mary L Townsend, Melanie W Pound, Richard H Drew
Therapeutics and Clinical Risk Management 2007, 3:1059-1070
Published Date: 15 January 2008
Optimizing medicines management: From compliance to concordance
Annie Cushing, Richard Metcalfe
Therapeutics and Clinical Risk Management 2007, 3:1047-1058
Published Date: 15 January 2008
Barrett’s esophagus: Incidence, etiology, pathophysiology, prevention and treatment
Nir Modiano, Lauren B Gerson
Therapeutics and Clinical Risk Management 2007, 3:1035-1045
Published Date: 15 January 2008
Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide
Mark R Gilbert, Terri S Armstrong
Therapeutics and Clinical Risk Management 2007, 3:1027-1033
Published Date: 15 January 2008
Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
Hae-Hyuk Lee, Torsten Zuberbier, Margitta Worm
Therapeutics and Clinical Risk Management 2007, 3:1021-1026
Published Date: 15 January 2008
Palonosetron as an anti-emetic and anti-nausea agent in oncology
Matti S Aapro
Therapeutics and Clinical Risk Management 2007, 3:1009-1020
Published Date: 15 January 2008
Photodynamic diagnosis for follow-up of carcinoma in situ of the bladder
Renzo Colombo, Richard Naspro, Piera Bellinzoni, Fabio Fabbri, Giorgio Guazzoni, et al
Therapeutics and Clinical Risk Management 2007, 3:1003-1007
Published Date: 15 January 2008
Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease
Chiara Bellia, Giulia Bivona, Concetta Scazzone, Marcello Ciaccio
Therapeutics and Clinical Risk Management 2007, 3:999-1001
Published Date: 15 January 2008
Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil
Divaldo Pereira de Lyra Júnior, Nadir Kheir, Juliana Palma Abriata, Chiara Ermínia da Rocha, Cláudia Benedita dos Santos, et al
Therapeutics and Clinical Risk Management 2007, 3:989-998
Published Date: 15 January 2008
Analysis of adherence to national nosocomial pneumonia treatment guidelines
Edward H Eiland III, Kurt A Wargo, Wayne Hamm, Ali AM Hassoun
Therapeutics and Clinical Risk Management 2007, 3:983-988
Published Date: 15 January 2008
Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction
James G McMurray, Robert A Feldman, Stephen M Auerbach, Herb DeRiesthal, Neal Wilson et al
Therapeutics and Clinical Risk Management 2007, 3:975-981
Published Date: 15 January 2008
Editorial: This issue of Therapeutics and Clinical Risk Management... ||Free Paper||
Garry M Walsh
Therapeutics and Clinical Risk Management 2007, 3:973-974
Published Date: 15 January 2008